Andersen vs HealthEquity
ANDG and HQY side by side, both in miscellaneous business services. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How ANDG and HQY compare
HealthEquity is the larger company, worth 1.2 times as much as Andersen ($8.4B against $7.1B).
HealthEquity scores higher on the StockData Score (15 against 4 for Andersen), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | ANDG | HQY |
|---|---|---|
| Size and price | ||
| Market cap | $7.1B | $8.4B |
| Share price | $63.08 | $101.84 |
| Change, 1 year | – | 0.07% |
| Change, 5 years | – | 77.5% |
| Beta (5Y) | – | 0.39 |
| Employees | 2,300 | 2,814 |
| StockData Score | ||
| Total score | 4 | 15 (better) |
| Valuation score | 0 | 3 (better) |
| Growth score | 1 | 3 (better) |
| Performance score | 0 | 4 (better) |
| Health score | 3 | 5 (better) |
| Dividend score | 0 | 0 |
| Valuation | ||
| P/E | – | 36.8× |
| P/S | 7.4× | 6.2× (better) |
| P/B | – | 4.2× |
| EV/EBITDA | – | 17.9× |
| P/FCF | 34.6× | 17.3× (better) |
| FCF yield | 2.9% | 5.8% (better) |
| Fair value | $13.52 | $110.02 |
| Margin of safety | −367% | 7.4% (better) |
| Growth | ||
| Revenue growth (TTM) | – | 7.3% |
| Revenue growth, 5Y average | – | 12.4% |
| Net income growth (TTM) | – | 62.2% |
| EPS growth (TTM) | – | 67.9% |
| EPS growth, 5Y average | – | 83.0% |
| Profitability | ||
| Gross margin | 32.6% | 71.2% (better) |
| Operating margin | −8.5% | 25.8% (better) |
| Net margin | – | 17.4% |
| FCF margin | 21.3% | 35.8% (better) |
| Return on equity | – | 11.4% |
| Return on invested capital | – | 9.8% |
| Financial health | ||
| Debt / equity | – | 0.47 |
| Net debt / EBITDA | – | 1.33 |
| Interest coverage | −4.3× | 6.7× (better) |
| Current ratio | 2.52 | 2.99 (better) |
| Altman Z-score | 6.83 (better) | 4.90 |
| Piotroski F-score | – | 9 |
| Dividends and buybacks | ||
| Buyback yield | – | 4.8% |
| Shareholder yield | 0.00% | 4.8% (better) |
| Ownership | ||
| Held by institutions | 14.7% | 109% |
| Held by insiders | 0.04% | 1.4% |
| Insider net buying, 12 months | −$5.3M | −$4.1M (better) |
| Superinvestors holding | 1 | – |
| Short interest, % of float | 2.3% | 6.7% |
Go deeper
- ANDG stock overview
- ANDG income statement
- ANDG valuation and score
- HQY stock overview
- HQY income statement
- HQY valuation and score
For information only, not investment advice. Check the source filings before relying on any figure.